Mondal S, Sheinin M, Rangasamy S, Pahan K
Front Cell Neurosci. 2024; 18:1375531.
PMID: 38835441
PMC: 11148333.
DOI: 10.3389/fncel.2024.1375531.
Knoedler L, Dean J, Diatta F, Thompson N, Knoedler S, Rhys R
Front Immunol. 2024; 15:1372862.
PMID: 38650942
PMC: 11033354.
DOI: 10.3389/fimmu.2024.1372862.
Azim S, Zubair H, Rousselle T, McDaniels J, Shetty A, Kuscu C
Am J Transplant. 2023; 23(9):1434-1445.
PMID: 37201755
PMC: 10527369.
DOI: 10.1016/j.ajt.2023.04.035.
Wang X, Zhou H, Liu Q, Cheng P, Zhao T, Yang T
Front Immunol. 2023; 14:1126761.
PMID: 36911741
PMC: 9995594.
DOI: 10.3389/fimmu.2023.1126761.
Puricelli C, Boggio E, Gigliotti C, Stoppa I, Sutti S, Rolla R
Pharmaceutics. 2022; 14(9).
PMID: 36145531
PMC: 9501480.
DOI: 10.3390/pharmaceutics14091782.
Islet allografts expressing a PD-L1 and IDO fusion protein evade immune rejection and reverse preexisting diabetes in immunocompetent mice without systemic immunosuppression.
Paul P, Das R, Drow T, Nylen E, Henrique de Souza A, Wang Z
Am J Transplant. 2022; 22(11):2571-2585.
PMID: 35897156
PMC: 9804298.
DOI: 10.1111/ajt.17162.
Mesenchymal stem cells augment regulatory T cell function via CD80-mediated interactions and promote allograft survival.
Mittal S, Cho W, Elbasiony E, Guan Y, Foulsham W, Chauhan S
Am J Transplant. 2022; 22(6):1564-1577.
PMID: 35170213
PMC: 11261724.
DOI: 10.1111/ajt.17001.
Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges.
Hefazi M, Bolivar-Wagers S, Blazar B
Int J Mol Sci. 2021; 22(18).
PMID: 34575843
PMC: 8469916.
DOI: 10.3390/ijms22189676.
Cytotoxic T Lymphocytes (CTLs) and Kidney Transplantation: An Overview.
Rascio F, Pontrelli P, Grandaliano G
Methods Mol Biol. 2021; 2325:203-213.
PMID: 34053060
DOI: 10.1007/978-1-0716-1507-2_14.
Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy.
Moorman C, Sohn S, Phee H
Front Immunol. 2021; 12:657768.
PMID: 33854514
PMC: 8039385.
DOI: 10.3389/fimmu.2021.657768.
The Therapeutic Potential of Regulatory T Cells: Challenges and Opportunities.
Bayati F, Mohammadi M, Valadi M, Jamshidi S, Foma A, Sharif-Paghaleh E
Front Immunol. 2021; 11:585819.
PMID: 33519807
PMC: 7844143.
DOI: 10.3389/fimmu.2020.585819.
Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation.
Lopez-Abente J, Martinez-Bonet M, Bernaldo-de-Quiros E, Camino M, Gil N, Panadero E
Sci Rep. 2021; 11(1):827.
PMID: 33436905
PMC: 7803770.
DOI: 10.1038/s41598-020-80567-9.
A Treg-Selective IL-2 Mutein Prevents the Formation of Factor VIII Inhibitors in Hemophilia Mice Treated With Factor VIII Gene Therapy.
Chen A, Cai X, Li C, Khoryati L, Gavin M, Miao C
Front Immunol. 2020; 11:638.
PMID: 32411127
PMC: 7198749.
DOI: 10.3389/fimmu.2020.00638.
Altered Tregs Differentiation and Impaired Autophagy Correlate to Atherosclerotic Disease.
Mandatori S, Pacella I, Marzolla V, Mammi C, Starace D, Padula F
Front Immunol. 2020; 11:350.
PMID: 32231663
PMC: 7082762.
DOI: 10.3389/fimmu.2020.00350.
Regulatory T cell modulation of cytokine and cellular networks in corneal graft rejection.
Tahvildari M, Inomata T, Amouzegar A, Dana R
Curr Ophthalmol Rep. 2019; 6(4):266-274.
PMID: 31807370
PMC: 6894425.
Plasmacytoid Dendritic Cell-driven Induction of Treg Is Strain Specific and Correlates With Spontaneous Acceptance of Kidney Allografts.
Oh N, OShea T, Ndishabandi D, Yuan Q, Hong S, Gans J
Transplantation. 2019; 104(1):39-53.
PMID: 31335760
PMC: 6933071.
DOI: 10.1097/TP.0000000000002867.
Phosphoinositide 3-kinase δ is a regulatory T-cell target in cancer immunotherapy.
Lim E, Okkenhaug K
Immunology. 2019; 157(3):210-218.
PMID: 31107985
PMC: 6587315.
DOI: 10.1111/imm.13082.
Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease.
Thangavelu G, Blazar B
Front Immunol. 2019; 10:309.
PMID: 30906290
PMC: 6419712.
DOI: 10.3389/fimmu.2019.00309.
Interleukin-6 neutralization prolongs corneal allograft survival.
Kodati S, Chauhan S, Chen Y, Emami-Naeini P, Omoto M, Dohlman T
Curr Trends Immunol. 2019; 19:105-113.
PMID: 30906117
PMC: 6428205.
Delayed allogeneic skin graft rejection in CD26-deficient mice.
Zhao X, Zhang K, Daniel P, Wisbrun N, Fuchs H, Fan H
Cell Mol Immunol. 2018; 16(6):557-567.
PMID: 29572550
PMC: 6804736.
DOI: 10.1038/s41423-018-0009-z.